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Abstract
Description of the phenomenology of movement disorders requires precise and accurate terminology. Many of the terms that have been widely used in the literature
are imprecise and open to interpretation. An examination of these terms and the assumptions implicit in their usage is important to improve communication and
hence the definition, diagnosis, and treatment of movement disorders. I recommend that the term dyskinesia should be used primarily in the settings of Parkinson’s
disease and tardive dyskinesia, in which its clinical implications are relatively clear; it should not be used in other situations where a precise description could more
usefully facilitate diagnosis and treatment. In general dyskinesia should be used in the singular form. Extrapyramidal is based upon obsolete anatomical concepts, is
uninformative, and should be discarded. The term abnormal involuntary movements (AIMs) is similarly vague and uninformative, although is unlikely to be eliminated
from the psychiatric literature. Movement disorder neurologists as teachers, clinicians, article reviewers, and journal editors have the responsibility to educate our
colleagues regarding appropriate usage and the importance of employing correct descriptors.
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Introduction
The widespread use of video recordings in recent years has
facilitated more homogeneous use of descriptive terms for various
movement disorders. While there is inevitable drift in meaning over
time,1 for example in usage of the term chorea, which originally
described a traditional Greek circle dance (xoroz), the appearance of
this movement disorder is at present fairly uniformly appreciated.
Two terms that are commonly used in the field of neurology in
general, and movement disorders in particular, are being widely
employed without consideration of their precise etymology. These terms
are dyskinesia and extrapyramidal. These words are often employed when
the observer is unable to provide a more exact description, whether
through lack of knowledge of the appropriate terminology or because
the movements are unusual, complex, and challenging to describe.
A third phrase, abnormal involuntary movements (AIMs), is used widely in
the psychiatric field but is similarly imprecise. Here, I discuss the usage
and meaning of these terms and make a plea for the use of more
accurate terminology.
Dyskinesia
This term, originating from the Greek, means abnormal movement, and
thus is imprecise by definition. It is often currently used to refer to two
specific conditions, levodopa-induced dyskinesia in Parkinson’s disease (PD),
and tardive dyskinesia induced by dopamine-blocking agents, in addition
to non-specific usage.
The plural dyskinesias is used very frequently and incorrectly. It
should be noted that dyskinesia is a mass noun (like water) and should
generally be used in the singular form, as chorea or parkinsonism. (One
would not say a dyskinesia.) The exception is when the term is used, as
with the plurals of the symptoms chorea, dystonia, parkinsonism, etc., to
refer collectively to the groups of disorders that cause these symptoms,
e.g. the genetic dystonias and the atypical parkinsonisms. Dyskinesias may also
be used to refer to several different hyperkinetic movements (e.g.,
dystonia and chorea).
The lack of specificity of the term is illustrated in The Encyclopedia
of Movement Disorders, as one example, in which this rather vague
definition of dyskinesia in the setting of PD is given:
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‘‘Dyskinesias are abnormal involuntary hyperkinetic movements
commonly observed in patients with PD chronically treated with
levodopa (levodopa induced dyskinesias (LIDs)) and rarely with
dopaminergic agonists,’’ which are ‘‘typically a mixture of
chorea, ballism, and dystonia or more rarely myoclonus.’’2
In PD, the nature of involuntary, hyperkinetic movements varies
depending upon the temporal relationship to medication dosing.
Movements can be irregularly irregular, flowing, or multi-focal (i.e.,
chorea), as is typical for the peak-dose dyskinesia or when the medication
is taking effect or wearing off (diphasic dyskinesia). Dystonia is more
usually seen when the patient is ‘‘off.’’ The appearance of the
movements and additional features are helpful in determining
appropriate management; thus, specificity is essential.
The movements of tardive dyskinesia can be complex and difficult
to describe.3 In some cases, the movements are flowing and irregular
and can be recognized as chorea. In others, there is clear dystonia with
the same muscle groups involved in repetitive movements, while some
cases exhibit sustained abnormal postures. In yet other situations,
involuntary movements are flowing but are more complex and
repetitive and may appear more like stereotypies. In some cases, there
may be confusion between tardive dyskinesia and drug-induced
parkinsonian tremor (Video).
The distinction between tardive chorea and tardive dystonia is
important. Tardive chorea is often not troublesome to patients and
typically does not interfere with tasks, such as speaking or eating. In
contrast, tardive dystonia can be very disabling, resulting, for example,
in action-induced jaw-opening or -closing movements, which interfere
with speaking and eating. The treatment of these entities differs. Anti-
cholinergics worsen or have no effect on tardive chorea but can
sometimes reduce tardive dystonia. Injections of botulinum toxin can
be helpful in treating tardive dystonia.
To add to the confusion, the episodic movement disorders known as
paroxysmal dyskinesias are at present classified with the dystonias, in
recognition of the nature of the predominant movement disorder. To
date, these include paroxysmal non-kinesigenic dyskinesia (DYT8),
paroxysmal kinesigenic dyskinesia (DYT10), and exertional dyskinesia
(DYT18). As inherited disorders are being increasingly classified in
terms of their genotype rather than their phenotype, I hope that the
genetic terminology will eventually be the defining language of these
disorders.
The term dyskinesia is also used relatively frequently, especially in
non-specialist literature, to refer to hyperkinetic movements that are
not otherwise defined.4–6 This usage obscures important differences in
etiology, pathophysiology, and therapy between different movement
disorders, typically chorea and dystonia, and thus perpetuates
confusion.
Extrapyramidal
The term extrapyramidal is technically an anatomic descriptor,
referring to structures located outside the pyramidal, or corticospinal,
tracts.7,8 Symptoms described as extrapyramidal are usually those
assumed to originate in the basal ganglia. However, this term could
technically be used to refer to symptoms due to lesions of almost any
other part of the brain, such as the cerebellum, brainstem, or
midbrain. The implication of this term is, of course, that some form of
movement disorder is present; however, this adjective is only
marginally informative without further definition.
At present, this term tends to be used particularly in the psychiatric
literature, often describing unwanted effects of psychiatric medications.
However, it still can be found even in the movement disorders
literature. Extrapyramidal is typically used to refer to tardive dyskinesia,
and hyperkinetic movement disorders in general, particularly chorea
and dystonia, but it may also describe parkinsonism.
Extrapyramidal appears to have been used initially in an experimental,
physiological context in the later part of the 19th centrury7,8 and was
first employed in a clinical context by Wilson in his report of familial
hepatolenticular degeneration.9 The original usage was based on an
understanding of a descending pathway that functioned in parallel
with and with complementary functions to the corticospinal tracts.7,8
As much of what is now understood about basal ganglia functioning
focuses upon their internal loops (e.g., striato-pallido-thalamo-cortico-
striatal) and influences cortical output, the concept of extrapyramidal
tracts with direct descending projections to spinal neurons is evidently
obsolete. While it has been proposed that the term be reserved as an
anatomical term for brainstem outflow tracts,8 this usage is likely to
Video. Female Patient with ‘‘Tardive Dyskinesia Affecting the
Hands.’’ This patient was referred by her psychiatrist for evaluation and
management of ‘‘tardive dyskinesia affecting the hands,’’ which interfered with her
activities of daily living. She has a staring expression; repetitive stereotypic
movements of the tongue and mouth; and a regular, large amplitude tremor of the
hands present at rest and with action. She was on haloperidol for chronic
schizophrenia. While the movements of her lower face were typical of tardive
dyskinesia, her staring expression with decreasing blinking indicated drug-induced
parkinsonism. Recognition of the hand movements as tremor (a term supplied by
the patient!), even though present both at rest and with action, was consistent with
this diagnosis. Conversion to quetiapine resolved the drug-induced parkinsonism
and improved the facial movements.
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result in further confusion, as being even further removed from the
clinical observation of movement disorders.
I recommend that ‘‘extrapyramidal symptoms’’ be referred to as
‘‘movement disorders’’, unless a more specific term can be employed.
Abnormal involuntary movements
The term abnormal involuntary movements (AIMs) is used
predominantly by psychiatrists to refer to any involuntary hyperkinetic
movements. The implication is that these movements are a side effect
of medications, and this term is typically used to describe tardive
dyskinesia due to dopamine-blocking anti-psychotic medications.10
This phrase is often used interchangeably with the Abnormal
Involuntary Movements Scale (AIMS) tool that rates the severity of
these movements11.
The AIMS is one of the major instruments used in the clinical
context to document movement distribution and severity. However,
this rating scale does not permit recognition of their true nature and
does not distinguish, for example, between chorea and dystonia, or if
movements are due to akathisia. In addition, while the instructions are
to exclude tremor, this is not always recognized, especially when severe
(Video).
The assumption implicit when the AIMS evaluation is performed is
that the movements are caused by medication use, and this may
obscure the realization that the movements are due to a progressive
neurodegenerative disorder, such as Huntington’s disease, which can
also be responsible for the patient’s psychiatric illness.
Conclusion
Clarity in language is essential for communication. The correct
definition of the observed phenomenology is essential to generate the
appropriate list of differential diagnoses, and hence treatment. While I
would like to discard the use of dyskinesia as imprecise and replace it
with chorea, dystonia, or other terms as appropriate, this term is so
entrenched in movement disorders literature that this is unlikely to
happen. I suggest that its use be restricted to the settings of PD and
tardive dyskinesia, in which its clinical implications are relatively clear,
but that it should not be used in other situations where a precise
description could more usefully facilitate diagnosis and treatment. As
discussed above, in most situations, dyskinesia should be used in the
singular form. Extrapyramidal is based upon obsolete anatomical
concepts and should be replaced with more informative terminology.
The term AIMs is similarly vague and uninformative, although it is
unlikely to be eliminated from the psychiatric literature.
As movement disorders neurologists, it is incumbent upon us to set
the standards for the description of involuntary movements. Reviewers
of articles and journal editors should insist upon precise and accurate
definitions whenever they come across these terms.
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